NIH grant review panels resume meeting after suspension

After being indefinitely suspended in the first days of the Trump administration, key National Institutes of Health committees that approve research grants resumed meeting this week. It appears to be a positive step toward restoring the flow of billions of dollars in biomedical research funding to universities and medical schools that for months has been significantly staunched.

While the NIH employs its own scientists, most of its roughly…